A board-certified medical oncologist, Hirva Mamdani, MD, specializes in the treatment of patients with thoracic cancers, including non-small cell and small cell lung cancer. Dr. Mamdani practices primarily at Winship Cancer Institute at Emory Midtown, where she is a member of the thoracic oncology team, and Emory Saint Joseph's Hospital.
Dr. Mamdani's clinical and research interests include immunotherapy, targeted therapies and novel treatment approaches for lung cancer. She has extensive experience leading early-phase and later-phase clinical trials in thoracic oncology and other solid tumors, including studies evaluating immune checkpoint inhibitors, molecularly targeted therapies and novel therapeutic agents.
Dr. Mamdani is an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Prior to joining Emory, Dr. Mamdani was an associate professor at Wayne State University School of Medicine and an associate professor in the Department of Oncology at Karmanos Cancer Institute in Detroit.
Dr. Mamdani received her medical degree from M.P. Shah Medical College at Saurashtra University in India. She completed her internal medicine residency at Wayne State University School of Medicine and a fellowship in hematology and oncology at Indiana University, where she served as chief fellow.
An active clinical investigator, Dr. Mamdani has served as principal investigator on numerous clinical trials and research studies, with a particular focus on non-small cell and small cell lung cancers, immunotherapy and precision oncology. Her research has been published in peer-reviewed journals including JAMA Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Cancer Research, Nature Communications, and Frontiers in Immunology.
Titles & Roles
Associate Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Education & Training
Education
Fellowship, 2017
Indiana University School of Medicine
Residency, 2014
Detroit Medical Center
Internship, 2012
Detroit Medical Center
Board Certifications
Hematology
American Board of Internal Medicine, 2017
Professional Memberships
Dr. Mamdani has served on the American Society of Clinical Oncology's expert panel for stage IV non-small cell lung cancer treatment guidelines and is active in national organizations including the American Society of Clinical Oncology, American Association for Cancer Research, International Association for the Study of Lung Cancer and Society for Immunotherapy of Cancer.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.